|
Over billions of years, nature has perfected enzymes as nature's ultimate catalysts. Yet, the vast majority of chemical reactions that power our
modern world don't exist in nature.
At Ligo Bio, we're pioneering a new era of biocatalysis by developing cutting-edge generative AI models that learn from nature's blueprint to design
entirely novel enzymes. Our technology is transforming the $6 trillion global chemical industry, enabling sustainable and efficient chemical processes
at scale.
We're proud to be supported by leading investors including A Capital, SV Angel, Hawktail, Liquid2, Soma Capital, Y Combinator, Paul Graham, and
Apoorva Mehta. Our team of four Oxford-trained AI researchers and scientists is driven by an unwavering commitment to revolutionize the chemical
industry through innovation, speed, and bold ambition.
We're building the future of industrial biotechnology - from designing enzymes that manufacture life-saving pharmaceuticals to developing biological
solutions that break down environmental toxins and neutralize chemical threats.
If you're passionate about using AI to solve some of the world's most pressing chemical challenges, we invite you to join our mission.